1683 studies found for:    HCV
Show Display Options
Rank Status Study
1 Completed Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C
Conditions: HCV Infection;   Liver Transplantation
Interventions: Biological: MBL-HCV1;   Other: 0.9% Sodium chloride Placebo
2 Recruiting Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
Condition: Hepatitis C Infection
Interventions: Biological: MBL-HCV1;   Drug: Telaprevir (Part 1);   Drug: Sofosbuvir (Part 2)
3 Completed Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C
Condition: Healthy
Intervention: Biological: MBL-HCV1
4 Completed HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
Condition: Hepatitis C
Intervention:
5 Completed Chiron Corp HCV E1/E2 Vaccine
Condition: Hepatitis C
Interventions: Biological: HCV E1E2/MF59;   Drug: Placebo
6 Terminated Long Term Vitamin D Therapy in HCV Treated Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Vitamin D
7 Completed
Has Results
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV;   Hepatitis C, Chronic;   HCV Coinfection
Intervention:
8 Completed Improving Hepatitis C Treatment in Injection Drug Users
Conditions: Hepatitis C;   Liver Diseases;   Drug Abuse;   Alcoholism
Interventions: Drug: Pegylated Interferon and Ribavirin;   Behavioral: Psychosocial;   Behavioral: On-site (MMT Clinic) HCV evaluation and treatment;   Behavioral: Off-site HCV evaluation and treatment
9 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
10 Not yet recruiting Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation
Conditions: Hepatitis C Virus;   Liver Transplantation
Intervention:
11 Recruiting Intensive Models of HCV Care for Injection Drug Users
Conditions: Hepatitis C;   Medication Adherence
Intervention: Other: Intensive Models (mDOT and CGT) of HCV Care
12 Completed Effect of Boceprevir on HCV-specific T Cell Responses
Condition: Chronic Hepatitis C
Intervention: Drug: Boceprevir
13 Recruiting Behavioral Science Aspects of Rapid Test Acceptance
Conditions: HIV;   Hepatitis C;   Hepatitis B;   Syphilis
Interventions: Device: Rapid tests for HIV, HCV, HBV, and syphilis;   Device: HIV/HCV;   Device: HIV/syphilis;   Device: HIV only
14 Recruiting Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Conditions: Hepatitis C Infection;   Viruses;   Hepatocellular Carcinoma;   Hepatitis, Viral, Human;   Liver Cirrhosis
Intervention: Biological: Civacir® 10%
15 Active, not recruiting Viral Kinetics in HCV Clearance in Subjects With Hemophilia
Condition: Hepatitis C With Hemophilia
Interventions: Other: Lead -In- PegInterferon + Ribavirin (4 weeks); PegInterferon + Ribavirin + Telaprevir (12 weeks); PegInterferon + Ribavirin (8 weeks);   Other: No Lead-in - No 4-week lead in therapy; PegInterferon + Ribavirin + Telaprevir (12 weeks); PegInterferon+ Ribavirin (12 weeks)
16 Completed Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:
17 Recruiting Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Conditions: Hepatitis C, Chronic;   Human Immunodeficiency Virus
Intervention: Drug: DAA against HCV
18 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
19 Completed
Has Results
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Condition: HIV-1 and Hepatitis C Co-Infection
Interventions: Drug: pioglitazone;   Drug: peginterferon;   Drug: ribavirin
20 Active, not recruiting Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment
Condition: Hepatitis C
Intervention: Drug: Boceprevir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years